Recent Company News

• 05:37 PM ET Dec 23, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:46 AM ET Jan 06, 2026
  

  StreetAccount Sector Summary: Healthcare Monthly Recap - December 2025

• 08:29 AM ET Dec 19, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:11 PM ET Jan 05, 2026
  

  Structure Therapeutics discloses license agreement with Genentech - 8-K ($62.77, 0.00)

• 06:31 PM ET Dec 22, 2025
  

  Novo Nordisk trading higher following FDA approval of Wegovy pill

• 09:18 AM ET Dec 19, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:21 AM ET Dec 19, 2025
  

  StreetAccount Summary - US Pre-market trading

• 08:32 AM ET Dec 17, 2025
  

  Structure Therapeutics initiates Phase 1 study of ACCG-2671 for the treatment of obesity ($61.71, 0.00)